The purpose of this open-label study was to investigate the effect of a curcumin-phospholipid lecithin formulation (Meriva®) on visual acuity and optical coherence tomography (OCT) retinal thickness in patients with chronic diabetic macular edema.
Oral administration of a curcumin-phospholipid formulation (Meriva®) for treatment of chronic diabetic macular edema: a pilot study
Eggenhoffner, R;
2018-01-01
Abstract
The purpose of this open-label study was to investigate the effect of a curcumin-phospholipid lecithin formulation (Meriva®) on visual acuity and optical coherence tomography (OCT) retinal thickness in patients with chronic diabetic macular edema.
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Mazzolani-Oral administration of a curcumin-phospholipid.pdf
accesso chiuso
Tipologia:
Documento in versione editoriale
Dimensione
4.92 MB
Formato
Adobe PDF
|
4.92 MB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
